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ABSTRACT Cryptococcosis is caused by the opportunistic pathogen Cryptococcus neoformans or by the primary pathogen Crypto-
coccus gattii. Epidemiological studies suggest that patients infected with C. gattii mainly present with pulmonary disease, while
those infected with C. neoformans commonly manifest meningoencephalitis. We compared the pathogenesis of the two species
using the C. neoformans H99 and C. gattii R265 strains in a murine inhalation model. C. neoformans grew faster in the brain
and caused death by meningoencephalitis, while C. gattii grew faster in the lungs and caused death without producing fulminat-
ingmeningoencephalitis.DespitetheconsistentfailuretorecoverR265cellsfromblood,afractionoftheR265populationwas
detectedintheextrapulmonaryorgans,includingthebrain.Uponintravenous(i.v.)inoculationof104cellsviathetailvein,
however, C. gattii produced severe meningoencephalitis, demonstrating that C. gattii cells can efﬁciently cross the blood-brain
barrier. Interestingly, i.v. inoculation with ﬁve cells caused brain infection in only 10% of C. gattii-infected mice, compared to
60% of mice infected with C. neoformans. In mice that had been initially inoculated via the pulmonary route and subsequently
challenged intravenously, a protective effect was observed only in mice infected with C. gattii. C. neoformans cells grew 10 to 100
times faster than C. gattii cells in blood or serum collected from naive mice. The paucity of meningoencephalitis upon inhala-
tion of C. gattii, therefore, may be partly due to an unknown factor(s) in the host’s blood coupled with immune protection that
reducesdisseminationtothebrainandfosterslunginfection.
IMPORTANCE While Cryptococcus neoformans is the most common cause of fatal meningoencephalitis, especially in HIV pa-
tients, Cryptococcus gattii causes disease mainly in non-HIV patients. Clinical studies revealed that most patients infected with
C. gattii VGII strains have lung infections with minimal brain involvement. Despite extensive clinicopathological studies on
cryptococcosis in animal models, only a few have included C. gattii. We compared the pathogenesis of the two species in mice
using an inhalation model. Similar to infection in humans, even though C. gattii can cross the blood-brain barrier, it failed to
cause fatal meningoencephalitis but caused fatal lung infection. We show that growth of C. gattii in mouse blood is signiﬁcantly
slower than that of C. neoformans and that a secondary protective phenomenon, though weak, manifests itself only in C. gattii
infection.Ourstudyprovidesamodelforunderstandingtheclinicopathologicaldifferencesbetweenthesetwocloselygeneti-
callyrelatedpathogens.
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T
he members of the Cryptococcus neoformans/Cryptococcus gat-
tiispeciescomplexcomprisethemostcommonfungalpatho-
gens that cause fatal central nervous system infection in humans
and also cause infections in a wide range of mammals (1, 2).
C. neoformans has been categorized as an AIDS-deﬁning oppor-
tunistic pathogen, while C. gattii is classiﬁed as a primary patho-
gen (3). Clinical perspectives on the diseases caused by the two
specieshavebeenwelldocumented(4).Thetwospecieshavebeen
categorized into eight molecular types: C. neoformans includes
molecular types VNI and VNII in serotype A, molecular type
VNIV in serotype D, and molecular type VNIII in the AD hybrid,
and C. gattii includes molecular types VGI to VGIV in serotype B
or C (5–8).
Amongthe4moleculartypeswithinC.neoformans,VNIisthe
most common cause of infection, occurring in approximately
80% of cases in HIV-infected patients and also in animal infec-
tions worldwide (9). Moreover, VNII, VNIII, and VNIV, though
signiﬁcantly less prevalent than VNI, have also been found to
cause disease, mainly in immunocompromised patients, with the
highest prevalence of VNIV being found in Europe (10, 11). Re-
cently, the status of C. neoformans as an opportunistic pathogen
was challenged by studies in Far East Asian countries reporting
that C. neoformans, especially VNI, infects mostly non-HIV pa-
tients with or without underlying conditions (12, 13). Whether
susceptibility to cryptococcosis is affected by the patients’ genetic
background and whether there are unique strain-dependent vir-
ulence factors warrant investigation.
Although cryptococcosis due to C. gattii is endemic in Austra-
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cryptococcosis outbreak emerged in Vancouver, Canada, in 1999
(15). Since then, C. gattii has attracted considerable attention as a
publichealthissue,andthenumberofresearcharticlesonC.gattii
has been increasing. C. gattii molecular type VGI is endemic in
Australia, with the highest incidence being found in aboriginal
populations of the Northern part of Australia, and was the ﬁrst
molecular type to be rigorously studied (14). Detailed studies on
thepathogenesisofC.gattiiVGIwereperformedusingaratmodel
and found that in contrast to the cases of C. neoformans infection
which resulted in spontaneous recovery (16), all rats succumbed
to infection. These results suggested that C. gattii is a primary
pathogen(17).Recently,VGIIhasdrawnmoreattentionthanany
other molecular type of C. gattii, since it was the cause of the
Canadian outbreak (15). As a result, literature on the epidemiol-
ogy and pathogenesis of C. gattii molecular type VGII has accu-
mulated rapidly (4, 10, 11, 17–20). The C. gattii genome project
initially selected WM276, the Australian environmental VGI
strain, and R265, the Canadian clinical VGII strain (21), for se-
quencing. C. gattii VGIII and VGIV, two less frequently isolated
molecular types, were also initially believed to be primary patho-
gens (8, 9). However, recent studies in Africa (22) and North
America(23)revealedthatincontrasttoVGIandVGII,theprev-
alenceofVGIIIandVGIVwasrelativelyhighamongisolatesfrom
HIV/AIDS patients with cryptococcosis.
While C. neoformans primarily causes central nervous system
(CNS) infection and only 35% of C. neoformans-infected patients
suffer from pulmonary infection (14, 24), approximately 70% of
thecasescausedbyC.gattiiincludeevidenceoflunginfection(14,
24).ThesmallnumberofCNSinfectionscausedbyC.gattiicom-
paredtothosecausedbyC.neoformansisevenmorestrikingwhen
thediseasecausedbyC.gattiiVGIItypeisconsidered.Galanisand
Macdougall reported that only 7.8% of cryptococcosis patients
infected with VGII had CNS involvement (24). Recently, host re-
sponses to C. neoformans VNI (H99) and C. gattii VGII (R265)
were compared using the mouse model (18). That report demon-
strated that R265 suppressed host immune responses more effec-
tively than H99 and suggested that this ﬁnding may partially ex-
plain why C. gattii infects immunocompetent patients more
readilythanC.neoformans(18).Thefateofcellsofthetwospecies
inoculated into mice, however, has not been compared, and the
difference in their pathogenesis is poorly understood. Thus, we
conductedacomparativestudyonpathogenesisofthetwospecies
using a mouse model.
RESULTS
Strains.Thegenome-sequencedstrainsC.neoformansH99(VNI)
and C. gattii R265 (VGII) were selected as representative strains
for the following reasons: (i) both strains were isolated from clin-
ical cases; (ii) H99 belongs to molecular type VNI, representing
the most common opportunistic pathogenic clade, while R265
belongs to VGII, representing a primary pathogen and the major
strainoftheVancouveroutbreak;(iii)bothstrainshavebeenmost
widely used as reference strains of the two species in studies of
genetics and pathogenesis; and (iv) the completed whole genome
sequences of both strains are invaluable for subsequent genetic
studies (21).
Fulminant meningoencephalitis occurs in mice infected
withH99butnotinthoseinfectedwithR265.Weﬁrstcompared
the differences in pathogenesis between H99 and R265 using an
inhalation model by inoculating yeast cells via intrapharyngeal
(i.p.) aspiration. A high inoculum (50,000 cells/mice) was used,
sincebothspeciesconsistentlykilledC57BL/6miceafterinfection
with this inoculum (10, 20, 25, 26). Mice infected with either spe-
cies began to die 3 weeks after inoculation. However, the mice
infected with R265 died faster than those infected with H99
(Fig. 1A) (P  0.027). Both species produced severe pulmonary
fungal burdens during the infection period (Fig. 1B). However,
the pulmonary fungal burden was consistently higher in mice in-
fectedwithR265thaninthoseinfectedwithH99fromday3until
just before the time of death (Fig. 1B). By 2 weeks after inocula-
tion, lungs of the mice infected with R265 were visibly larger than
those inoculated with H99 (see Fig. S1 in the supplemental mate-
rial).Inthebrain,H99cellsweredetectedasearlyastheﬁrstweek
afterinoculationandreached106to108CFU/brainbythetimeof
death(Fig.1C)withseveremeningoencephalitis(seeFig.S2inthe
supplemental material). In contrast, R265 cells were not detected
in the brain until the third week after inoculation, and only 0 to
102 CFU were recovered from tissue without any sign of menin-
goencephalitisatthetimeofdeath(Fig.1C;also,seeFig.S2inthe
supplemental material). Similar to the results for fungal burdens
obtainedfromthebrains,highernumbersofH99CFUthanR265
CFU were recovered from spleens and kidneys (Fig. 1D and E).
Surprisingly, although yeast cells could be recovered from every
extrapulmonaryorganexamined,R265wasneverrecoveredfrom
blood, even at the time of death. Blood cultured from mice in-
fected with H99, on the other hand, yielded CFU occasionally at
3 weeks after inoculation and consistently near the time of death
(Fig.1F).SincenoR265cellscouldberecoveredfrombloodofthe
infected mice and yet R265 cells disseminated to the extrapulmo-
nary organs, we speculate that fungemia due to R265 occurred
transientlyand/oratanundetectablelevel.Thesedatasuggestthat
both R265 and H99 can exit from the lung and disseminate to
other organs but R265 fails to establish infection in the extrapul-
monary organs as readily as the H99 strain.
Host immune response in the lungs of mice infected with
R265isminimalcomparedtothatinmiceinfectedwithH99.A
previousstudyshowedthatthehostimmuneresponseofthelung
tocryptococcalinfectionincludedincreasednumbersofactivated
macrophages, neutrophils, and lymphocytes (18). Similar results
were found in this study. Leukocyte inﬁltrations in the lungs of
mice infected with R265 were mostly minimal relative to those in
mice infected with H99 in both early (see Fig. S3A and B in the
supplemental material) and late (see Fig. S3C and D in the sup-
plementalmaterial)timepoints.Moreover,despitebeingsmaller,
R265 produced as many giant cells as H99, which was consistent
with previous reports (27, 28).
Results with BALB/c mice are congruent with ﬁndings in
C57BL/6 mice. To conﬁrm that the difference in pathogenesis
between the two species is not mouse strain speciﬁc, we repeated
the experiment with BALB/c mice, which were used in previous
studies for both C. neoformans and C. gattii infections (20, 26). In
the BALB/c strain, no difference was found in the virulence be-
tween the two strains (see Fig. S4A in the supplemental material).
As in C57BL/6 mice, both strains caused a progressive increase in
the fungal burden in the lungs after i.p. inoculation, although the
numbers were higher from day 3 to day 14 with R265 than with
H99(seeFig.S4Binthesupplementalmaterial).Only0to10CFU
were recovered from the brains of mice infected with R265 with-
out any visible lesions at the time of death (see Fig. S3C in the
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with106to108CFUwasfoundinthebrainsofmiceinfectedwith
H99 at the time of death (see Fig. S3C in the supplemental mate-
rial; also data not shown).
Since the fungal burden in the extrapulmonary organs was
muchlowerforR265-infectedmice,weinvestigatedwhethersuch
adifferencewouldbepresentinmiceinfectedbyadifferentroute.
BALB/cmicewereinjectedintravenously(i.v.)with50,000cellsof
FIG 1 Heavy brain fungal burden is found only in mice infected with H99, not in those infected with R265. C57BL/6 mice were inoculated by intrapharyngeal
(i.p.) aspiration of 50,000 yeast cells/mouse. At least 3 mice were sacriﬁced at each time point for fungal load determination. (A) Survival curves were obtained
from a study of 10 mice per group, which was independent of the time course study. (B to F) CFU in each organ at the indicated time points. Error bars show
2 standard deviations (SD). *, P  0.05.
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faster than those infected with H99 (Fig. 2A) (P  0.005). Both
strainsestablishedinfectionequallywellinthelungs(Fig.2B).All
mice infected i.v. with H99 showed signs of severe brain infection
withahighloadofcryptococcalcells(Fig.2C).Cysticlesionswere
found throughout brain sections. In contrast to mice inoculated
viathei.p.route,miceinoculatedi.v.withR265didmanifestsigns
of severe brain infection with a high load of cryptococcal cells,
although the rate of increase of the fungal burdens was slightly
lower than that in H99-infected mice (Fig. 2C). Interestingly,
brain lesions showing prominent cryptococcomas with hemor-
rhage were common with R265 but rare with H99 (see Fig. S5 in
the supplemental material). These data clearly indicate that R265
can invade the brain and establish infection if large numbers of
cells are inoculated into the bloodstream. Therefore, the reason
forthelowerfungalburdenintheextrapulmonaryorgansinmice
infected with R265 i.p. remains to be determined.
Intravenous inoculation of mice with low inocula causes in-
fectionmoreconsistentlywithH99thanR265.Inouri.p.model,
numbers of R265 CFU in the extrapulmonary organs were signif-
icantly lower than those for H99 and were undetectable in circu-
lating blood (Fig. 1). We hypothesize that the lower fungal bur-
dens of R265 in extrapulmonary organs was due to the very low
numberofcirculatingcellsintheblood.SinceR265fungemiawas
belowthelevelofdetection(Fig.1F),weassumedthatthenumber
ofcryptococcalcellsinbloodstreamwasbelow3perml.Tomimic
fungemiaini.p.infection,weinoculatedverylownumbersofcells
(5 and 50 cells) of either H99 or R265 into BALB/c mice intrave-
nously. In contrast to the result with the high inoculum (Fig. 2),
H99 was far more virulent than R265 with 5 or 50 cells (Fig. 3).
Withtheinoculumof5cells,asmanyas9of10miceinfectedwith
R265 cleared the infection, while only 4 of 10 mice infected with
H99 cleared the infection (Table 1). Similarly, with an inoculum
of 50 cells, H99 caused infection more consistently than R265
(Table1).Theseresultssuggestthatwhenverylownumbersofthe
cells are introduced into the bloodstream, R265 cells are less able
to establish infection in host tissues (brain, lung, and spleen).
Growth of R265 is inferior to that of H99 in whole blood or
serumofmice.ThelowrecoveryofR265frombloodandreduced
abilitytocauseinfectioninexperimentsusingverylowi.v.inocula
FIG2 R265causesseverebraininfectioninanintravenous(i.v.)model.BALB/cmicewereinoculatedwith50,000cells/mouseofH99orR265viathei.v.route.
Atleast3miceeachweresacriﬁcedateachtimepointforthedeterminationofthefungaltissueload.Survivalcurves(A)weregeneratedfromtheresultsobtained
with 10 mice per group, which are independent of the time course study (B and C). Error bars show 2 SD. *, P  0.05.
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the blood. Thus, we compared the growth rates of H99 and R265
inwholebloodaswellasserumcollectedfromnaivemiceinvitro.
To mimic mammalian body conditions, both strains were incu-
bated in blood, serum, or RPMI at 37°C with 5% CO2. Interest-
ingly,H99grewsigniﬁcantlybetterthanR265inbothwholeblood
andserum(Fig.4AandB),whilebothstrainsgrewequallywellin
RPMI (Fig. 4C). In order to determine if the disparity in growth
rates between H99 and R265 in mouse serum was related to nu-
trient availability, cells were incubated in phosphate-buffered sa-
line (PBS) containing 10% (vol/vol) RPMI or in serum supple-
mentedwith10%(vol/vol)RPMI.ThenumbersofCFUofthetwo
strains were similar in PBS containing 10% RPMI after 48 h of
incubation,butthegrowthdifferencebetweenH99andR265per-
sisted in the serum supplemented with 10% RPMI (see Fig. S6 in
the supplemental material). We also used heated versus non-
heated serum, and the growth difference between two strains re-
mained in those two conditions (data not shown). These results
indicatethatthedifferenceisnotduetoeithernutrientlimitation
or complement differentially suppressing the growth of C. gattii.
IntrapulmonaryinfectionwithR265slightlyenhancestoler-
anceofthemicetosubsequentinfectionviai.v.inoculation.We
hypothesized that the establishment of infection ﬁrst in the lungs
(by i.p. inoculations) might activate the host immune system and
affect the ability of yeast cells to disseminate to extrapulmonary
organs in R265-infected mice. As a result, signiﬁcantly lower fun-
gal burden in extrapulmonary organs might be found in these
micethaninH99-infectedmice.Thus,weﬁrstinoculatedmicevia
i.p.with50yeastcellsofH99orR265andchallengedthem2weeks
later with 500 or 5,000 cells of the same strains i.v. (dual inocula-
tion). The survival of the mice was monitored. The 2-week inter-
val before the second challenge was chosen because it reﬂects the
timewhenyeastcellsstarttoappearintheextrapulmonaryorgans
(Fig. 1; also, see Fig. S4 in the supplemental material). Compared
to the control mice (i.e., mice that were not preinfected), the dual
inoculation of either 500 or 5,000 cells prolonged the survival of
R265preinfectedmiceforseveraldaysbutnotthesurvivalofH99
preinfected mice (Fig. 5; Table 2). In a control group of mice
inoculated i.p. with approximately 50 CFU of H99 or R265 with
no subsequent i.v. challenge, all survived throughout the experi-
ment(datanotshown).Theseresultssuggestthatpreintrapulmo-
naryinfectionwithR265mayaffordthemicebetterimmunepro-
tection than infection with H99 during subsequent exposure to
cryptococci introduced via the intravenous route.
DISCUSSION
Relative to C. neoformans, C. gattii more frequently causes lung
infections, and C. gattii VGII strains especially are less frequently
reported to be neurotropic in the human host (4, 14, 24, 29). This
clinical observation was conﬁrmed by our animal experiments.
MiceinfectedviathepulmonaryroutewithH99appearedtohave
beenkilledbybraininfection,whilethoseinfectedwithR265were
killed by lung infection, in both BALB/c and C57BL/6 strains.
Interestingly,whileinferiortoH99inextrapulmonarydissemina-
FIG 3 H99 is more virulent than R265 when mice are inoculated with very low numbers of cells i.v. Eight to ten BALB/c mice were inoculated i.v. with
approximately 5 or 50 cells of H99 or R265, and the survival of mice was monitored.
TABLE 1 Numbers of mice that succumbed to or cleared infection after i.v. inoculation with a very small inoculum
Inoculum size (no. of cells) Strain
No. (%) of mice that:
Succumbed to infection Cleared infection and surviveda
50 H99 8 (100) 0 (0)
R265 3 (38) 5 (62)
5 H99 6 (60) 4 (40)
R265 1 (10) 9 (90)
a “Cleared” is deﬁned as no CFU detected in the brain, lungs, or spleen.
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may be explained by stronger pulmonary immunosuppression
with R265, as fewer inﬂammatory cells were present in lungs in-
fectedwithR265thaninlungsinfectedwithH99.Chengetal.(18)
reportedsimilarﬁndingswithC.gattiistrains,includingtheR265
strain, which was isolated from Vancouver outbreak cases. All the
C.gattiistrainsinducedalessprotectiveinﬂammatoryresponsein
C57BL/6 mice by suppressing neutrophil migration to the infec-
tionsites.Chengetal.alsofoundthatC.gattiistrainsfailedtoelicit
the production of protective cytokines, such as tumor necrosis
factor, in comparison with H99 (18). However, the difference be-
tween C. gattii and C. neoformans in terms of their fate during
infection has not been elucidated. We expanded on the patholog-
ical differences between the two species by monitoring the fate of
theyeastcellsinoculatedviatwodifferentroutes.Ourresultssup-
port the previous report (18), but details of the immunosuppres-
sive mechanisms that C. gattii employs have yet to be deciphered.
The adaptive immune response, both antibody mediated and
cell meditated, has been proven to be essential against cryptococ-
cal infection (30). C. gattii cannot cause fulminant meningoen-
cephalitis upon pulmonary inoculation, although the yeast cells
musthavebeenreleasedintothebloodstream,sincetheycancross
the blood-brain barrier (BBB). We speculate, therefore, that the
host may manifest stronger protective immunity against R265.
This speculation is supported by the fact that mice infected intra-
venously with R265 survived longer than those infected with H99
when they had been preinfected via the pulmonary route 2 weeks
priortotheintravenouschallenge.Ontheotherhand,whenmice
were preinfected with R265 via the pulmonary route and chal-
lenged by intravenous inoculation after 5 days, their survival was
not prolonged (data not shown). These ﬁndings suggest that an
adaptive systemic immune response likely affects the dissemina-
tion to the brain and delays the establishment of severe meningo-
encephalitis in mice infected with R265 but not those infected
with H99.
Since the protective effect of dual infections was not robust
enough to prolong survival in R265 infected mice, additional
mechanisms may prevent R265 from causing fulminating brain
infection. In fact, even with a single high-dose i.v. inoculum, the
fungal load of R265 in the brains was lower than that of H99
(Fig.2).Furthermore,whilemostmiceinfectedwithaverylowi.v.
inoculum of R265 cleared the infection, the majority of mice in-
fected with the same number of H99 cells did not (Table 1). In
light of the consistent failure to recover R265 from the blood of
mice inoculated intrapharyngeally (i.p.) and the poor yield of
R265 in blood or serum cultures in vitro, it was not surprising to
ﬁnd limited numbers of CFU in extrapulmonary organs. Al-
though the detailed immunological mechanism has yet to be in-
FIG 4 Lower growth of R265 than H99 in murine blood and serum. Blood or serum was collected from naive C57BL/6 mice. Yeast cells were diluted and
incubated in 100 l of whole blood, serum, or RPMI with 5% CO2 at 37°C for the indicated period, and numbers of CFU were recorded. Error bars show 1 SD.
*, P  0.05.
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mune responses to the two species. Therefore, comparative
studies on the detailed host immunological response to C. neofor-
mans versus C. gattii are warranted.
The mechanism by which C. neoformans cells cross the blood-
brain barrier (BBB) has been studied extensively, and both direct
transcytosis (31) and a Trojan horse mechanism (32) have been
proposed. A recent study using intravital microscopy reported
that crossing the BBB by C. neoformans is urease dependent, re-
quires viability, and involves cellular deformation, which suggest
direct invasion (33). To date, however, neither mechanism has
been conﬁrmed directly within the host. It is possible that C. neo-
formansmayusebothmechanismstocrosstheBBB(34).Whether
and how C. gattii crosses the BBB has never been studied. When
mice were inoculated via the i.p. route, C. gattii disseminated to
thebrainfarlesseffectivelythanC.neoformansandfailedtocause
meningoencephalitisdespiteitshighergrowthrateinthelungs.At
thetimeofdeath,only0to200and0to20CFUwerefoundinthe
brains of R265-infected C57BL/6 and BALB/c mice, respectively,
indicating that death was not caused by a brain disease. This was
alsotrueevenwithi.v.inoculationwhentheinoculumsizewas50
cellsorless.SincegrowthofC.gattiiinbloodorseruminvitrowas
signiﬁcantly slower than that of C. neoformans, there may be a
factor(s)inmousebloodorserumthatinhibitsC.gattiicellsfrom
multiplying and eventually reaching the brain. However, R265
caused severe meningoencephalitis when the i.v. inoculum was
large (50,000 cells/mouse). Even with the large inoculum, the
brain fungal load of R265 trailed that of H99. These data suggest
that R265 can cross the BBB and invade the brain but less efﬁ-
ciently than H99. The pattern of CNS infection is also different
between the two species, since prominent cryptococcomas with
hemorrhage were commonly observed in mice infected intrave-
FIG 5 Preintrapulmonary infection slightly prolongs the survival of mice subsequently infected with R265 via i.v. inoculation. Five to eight BALB/c mice per
groupwereused.Micewereﬁrstinoculatedi.p.withapproximately50cellsofH99orR265.After2weeks,thepreinfectedandnaivemicewereinjectedi.v.with
approximately 500 or 5,000 cells of H99 or R265. The survival of the mice was recorded.
TABLE 2 Comparison of median survival times of mice infected by i.v.
inoculation and dually infected mice
Inoculum size (CFU) Infection route
Median survival (days)
H99 R265
5,000 i.v. 16 11
Dual 16 14
500 i.v. 38 32
Dual 40 46
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(see Fig. S5 in the supplemental material; also data not shown).
In conclusion, our study validates previous reports on clinical
manifestations of the two agents of cryptococcosis (4): mice in-
fected with C. gattii R265 strain via the pulmonary route died due
to overwhelming intrapulmonary growth, while those infected
with H99 died due to fulminating brain disease. Despite the dif-
ferencesintheirclinicopathology,bothH99andR265crossedthe
blood-brain barrier effectively and established fatal brain infec-
tion upon intravenous inoculation. Although the growth rate of
R265inthebloodwaslowerthanthatofH99invitro,thisdoesnot
explain why mice infected with R265 via the pulmonary route
failed to exhibit fatal meningoencephalitis. For instance, mice in-
fected via inhalation with 50 R265 cells survived for more than
90dayswithoutnoticeablebrainlesions,whileani.v.inoculumof
ﬁve R265 cells established fatal brain infection in 10% of mice in
less than 30 days. It is possible that some immunological protec-
tionresultingduringlunginfectionprovidedanadditionalmech-
anism(s) for reducing R265 dissemination to the extrapulmonary
organs. Thus, it can be assumed that both innate and adaptive
immune responses are responsible for such containment of C.
gattii. However, it is paradoxical, since R265 induces a relatively
poor inﬂammatory response compared to H99 and yet can pro-
duce more adaptive immunity. The observation that growth of C.
gattii in the blood or serum is clearly slower than that of C. neo-
formans raises the question of whether there are factors in mouse
blood that actively suppress R265 but not H99 and might be fur-
ther induced during infection. This would offer some protection
against blood exposure to R265 but not H99. It is important to
ﬁnd anti-C. gattii compounds in serum, since the agent in ques-
tion does not appear to be complement. We believe our results
have laid the foundation for further in-depth studies of the host
immune response to the two species.
MATERIALS AND METHODS
Strainsandmedia.ThestrainsH99andR265werechosenasrepresenta-
tivestrainsofC.neoformansandC.gattii,respectively.Strainsweremain-
tained on YPD agar (2% glucose, 1% yeast extract, 2% peptone and 2%
Bacto agar) throughout the experiment.
Animal study. The animal experiments were carried out with the ap-
proval and oversight of the Animal Care and Use Committee of the Na-
tional Institute of Allergy and Infectious Diseases, National Institutes of
Health.Six-toeight-week-oldC57BL/6andBALB/cmicewerepurchased
from DCT (National Cancer Institute, NCI-Frederick, MD). Mice were
inoculated with the designated number of yeast cells via intrapharyngeal
(i.p.) aspiration (inhalation method) (35, 36) or tail vein (i.v.) injection.
Brieﬂy, yeast cells were grown in YPD broth overnight and diluted in 1
phosphate-bufferedsaline(PBS)tothedesiredconcentrations.Inthecase
of i.p. inoculation, 20 l of the yeast suspension was administered in-
trapharyngeallyaftermicewereanesthetizedwithisoﬂurane.Inthecaseof
i.v.injection,200loftheyeastsuspensionwasinjectedintothetailvein.
Mice were provided with food and water ad libitum, and survival was
monitored up to 6 months.
Organfungalburdens.MicewereeuthanizedbyinhalationofCO2or
an overdose of pentobarbitone (200 mg/kg intraperitoneally). The lungs,
spleens,kidneys,andbrainweredissectedfortheanalysisofCFU.Brieﬂy,
eachorganwashomogenizedinPBS,diluted,andplatedonYPDagarfor
colony counts. While mice were under the effect of overdose pentobarbi-
tone,300to800lofbloodwaswithdrawnfromheartusinganeedleand
syringe containing 0.01% EDTA and then plated directly on YPD agar.
Histology. Each organ was ﬁxed in 4% neutral buffered formalin,
processed, and embedded in parafﬁn. Tissue sections were stained with
hematoxylin and eosin (H&E) or Grocott’s methenamine silver (GMS)
stain. The presence or absence of yeast cells, their morphology and loca-
tion (intracellular or extracellular), and the host inﬂammatory response
and the distribution of immune cells within the tissues were recorded.
Growth in whole blood or serum. Whole blood was collected from
naive mice via heart puncture as mentioned above. EDTA (0.01%) or
heparin (30 IU/ml) was used as an anticoagulant for blood collection.
Serumwascollectedbydrawingoffthesupernatantaftercentrifugationof
clotted whole blood at 1,300  g for 15 min, and 10 to 100 yeast cells of
eachstrainwereinoculatedinto100lofwholeblood,serum,orRPMIin
round-bottom 96-well plates and incubated for 24 and 48 h at 37°C with
5% CO2. CFU were counted by plating the incubation mixtures on YPD
agar.
Statistical analysis. The t test and Kaplan-Meier survival test were
performed using an SPSS statistics 17.0 program.
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